logo

TDOC

Teladoc Health·NYSE
--
--(--)
--
--(--)
0.81 / 10
Underperform

TDOC's fundamental score is subpar (0.8/10). Key concerns include a high fixed assets turnover ratio (32.59) in the worst quartile, declining total operating revenue (-2.14% YoY) and operating revenue (-2.14% YoY), and a negative net cash flow from operations (-0.56% YoY). Although the interest coverage ratio (15.48) is decent, it is offset by other deteriorating factors, leading to an overall 'Underperform' rating.

Fundamental(0.81)SentimentTechnical

Analysis Checks(3/10)

Total operating revenue (YoY growth rate %)
Value-2.14
Score1/3
Weight10.19%
1M Return-3.52%
Quick ratio
Value2.60
Score1/3
Weight11.73%
1M Return-2.86%
Total profit (YoY growth rate %)
Value78.64
Score1/3
Weight16.93%
1M Return-4.59%
Net cash flow from operating activities (YoY growth rate %)
Value-0.56
Score3/3
Weight-19.51%
1M Return3.96%
Fixed assets turnover ratio
Value32.59
Score0/3
Weight20.26%
1M Return-5.85%
Long-term debt to working capital ratio (%)
Value1.57
Score0/3
Weight16.40%
1M Return-4.72%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight6.77%
1M Return-1.71%
Operating revenue (YoY growth rate %)
Value-2.14
Score1/3
Weight10.19%
1M Return-3.52%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value81.61
Score0/3
Weight19.99%
1M Return-5.92%
Inventory turnover days
Value18.34
Score2/3
Weight7.04%
1M Return-1.96%
Is TDOC undervalued or overvalued?
  • TDOC scores 0.81/10 on fundamentals and holds a Premium valuation at present. Backed by its -12.15% ROE, -8.84% net margin, -3.98 P/E ratio, 0.64 P/B ratio, and 78.20% earnings growth, these metrics solidify its Underperform investment rating.